The SignGene Symposium 2016 in Potsdam will consider recent progress in the understanding of regulatory processes in gene expression and proteostasis control with primary relevance to cancer. The Symposium brings together invited speakers from Europe, Israel and the USA, as well as SignGene students and investigators, who will present novel cutting edge results and innovative experimental and computational approaches.


Yehudit Bergman, Hebrew University of Jerusalem, Israel

Walter Birchmeier, MDC Berlin, Germany

Nir Friedman, Hebrew University of Jerusalem, Israel

Michael Glickman, Technion, Haifa, Israel

Undine Hill, MDC Berlin, Germany

Bo Hu, MDC Berlin, Germany

Jan Philipp Junker, MDC Berlin, Germany

Michael Karin, UC San Diego, CA, USA

Edda Klipp, Humboldt University, Berlin, Germany

Frank Lyko, DKFZ, Heidelberg, Germany

Ulrike Münzner, Humboldt University, Berlin, Germany

Kees Murre, UC San Diego, CA, USA

Gioacchino Natoli, IFOM-IEO, Milan, Italy

Ana Pombo, MDC & HU Berlin, Germany

Ze'ev Ronai, Technion, Haifa, Israel & La Jolla, CA, USA

Claus Scheidereit, MDC Berlin, Germany

Thomas Sommer, MDC & HU Berlin, Germany

Erwin Wagner, CNIO Madrid, Spain

Additional Information

Organizing Committee

Yehudit Bergman (Hebrew University of Jerusalem)
Claus Scheidereit (MDC Berlin)
Sandra Krull (MDC Berlin)


Dr. Sandra Krull
Max Delbrück Center for Molecular Medicine
Robert-Rössle-Str 10
13125 Berlin

Phone: +49 30 9406 4205
Fax: +49 30 9406 2170